177Lu-anti-PD-L1 sdAb

· Radiopharm Theranostics, Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 177Lu-anti-PD-L1 sdAb, covering 2026-02-19 to 2026-02-19. Get the full timeline:

Most recent: Clinical Trial Update: 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors [EARLY_Phase 1]